These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

743 related articles for article (PubMed ID: 28459449)

  • 21. Mouse model of proximal colon-specific tumorigenesis driven by microsatellite instability-induced Cre-mediated inactivation of Apc and activation of Kras.
    Kawaguchi Y; Hinoi T; Saito Y; Adachi T; Miguchi M; Niitsu H; Sasada T; Shimomura M; Egi H; Oka S; Tanaka S; Chayama K; Sentani K; Oue N; Yasui W; Ohdan H
    J Gastroenterol; 2016 May; 51(5):447-57. PubMed ID: 26361962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of CRISPR-Cas9 based gene editing to study the pathogenesis of colon and liver cancer using organoids.
    Ramakrishna G; Babu PE; Singh R; Trehanpati N
    Hepatol Int; 2021 Dec; 15(6):1309-1317. PubMed ID: 34596864
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genetic editing of colonic organoids provides a molecularly distinct and orthotopic preclinical model of serrated carcinogenesis.
    Lannagan TRM; Lee YK; Wang T; Roper J; Bettington ML; Fennell L; Vrbanac L; Jonavicius L; Somashekar R; Gieniec K; Yang M; Ng JQ; Suzuki N; Ichinose M; Wright JA; Kobayashi H; Putoczki TL; Hayakawa Y; Leedham SJ; Abud HE; Yilmaz ÖH; Marker J; Klebe S; Wirapati P; Mukherjee S; Tejpar S; Leggett BA; Whitehall VLJ; Worthley DL; Woods SL
    Gut; 2019 Apr; 68(4):684-692. PubMed ID: 29666172
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platforms of in vivo genome editing with inducible Cas9 for advanced cancer modeling.
    Jo N; Sogabe Y; Yamada Y; Ukai T; Kagawa H; Mitsunaga K; Woltjen K; Yamada Y
    Cancer Sci; 2019 Mar; 110(3):926-938. PubMed ID: 30588718
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probing the Tumor Suppressor Function of BAP1 in CRISPR-Engineered Human Liver Organoids.
    Artegiani B; van Voorthuijsen L; Lindeboom RGH; Seinstra D; Heo I; Tapia P; López-Iglesias C; Postrach D; Dayton T; Oka R; Hu H; van Boxtel R; van Es JH; Offerhaus J; Peters PJ; van Rheenen J; Vermeulen M; Clevers H
    Cell Stem Cell; 2019 Jun; 24(6):927-943.e6. PubMed ID: 31130514
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Novel CRISPR/Cas9-mediated Mouse Model of Colon Carcinogenesis.
    Kashima H; Fischer A; Veronese-Paniagua DA; Gazit VA; Ma C; Yan Y; Levin MS; Madison BB; Rubin DC
    Cell Mol Gastroenterol Hepatol; 2024; 18(5):101390. PubMed ID: 39128652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostaglandin E2 Promotes Colorectal Cancer Stem Cell Expansion and Metastasis in Mice.
    Wang D; Fu L; Sun H; Guo L; DuBois RN
    Gastroenterology; 2015 Dec; 149(7):1884-1895.e4. PubMed ID: 26261008
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRISPR-SID: Identifying EZH2 as a druggable target for desmoid tumors via in vivo dependency mapping.
    Naert T; Tulkens D; Van Nieuwenhuysen T; Przybyl J; Demuynck S; van de Rijn M; Al-Jazrawe M; Alman BA; Coucke PJ; De Leeneer K; Vanhove C; Savvides SN; Creytens D; Vleminckx K
    Proc Natl Acad Sci U S A; 2021 Nov; 118(47):. PubMed ID: 34789568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quadruple-editing of the MAPK and PI3K pathways effectively blocks the progression of KRAS-mutated colorectal cancer cells.
    Wang Z; Kang B; Gao Q; Huang L; Di J; Fan Y; Yu J; Jiang B; Gao F; Wang D; Sun H; Gu Y; Li J; Su X
    Cancer Sci; 2021 Sep; 112(9):3895-3910. PubMed ID: 34185934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NHE8 Deficiency Promotes Colitis-Associated Cancer in Mice via Expansion of Lgr5-Expressing Cells.
    Xu H; Li J; Chen H; Ghishan FK
    Cell Mol Gastroenterol Hepatol; 2019; 7(1):19-31. PubMed ID: 30465020
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic dissection of colorectal cancer progression by orthotopic transplantation of engineered cancer organoids.
    Fumagalli A; Drost J; Suijkerbuijk SJ; van Boxtel R; de Ligt J; Offerhaus GJ; Begthel H; Beerling E; Tan EH; Sansom OJ; Cuppen E; Clevers H; van Rheenen J
    Proc Natl Acad Sci U S A; 2017 Mar; 114(12):E2357-E2364. PubMed ID: 28270604
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vivo profiling of metastatic double knockouts through CRISPR-Cpf1 screens.
    Chow RD; Wang G; Ye L; Codina A; Kim HR; Shen L; Dong MB; Errami Y; Chen S
    Nat Methods; 2019 May; 16(5):405-408. PubMed ID: 30962622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. CRISPR/Cas 9 genome editing and its applications in organoids.
    Driehuis E; Clevers H
    Am J Physiol Gastrointest Liver Physiol; 2017 Mar; 312(3):G257-G265. PubMed ID: 28126704
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In Vivo Genome Editing Restores Dystrophin Expression and Cardiac Function in Dystrophic Mice.
    El Refaey M; Xu L; Gao Y; Canan BD; Adesanya TMA; Warner SC; Akagi K; Symer DE; Mohler PJ; Ma J; Janssen PML; Han R
    Circ Res; 2017 Sep; 121(8):923-929. PubMed ID: 28790199
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Advance genome editing technologies in the treatment of human diseases: CRISPR therapy (Review).
    Alagoz M; Kherad N
    Int J Mol Med; 2020 Aug; 46(2):521-534. PubMed ID: 32467995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Doxycycline-Dependent Self-Inactivation of CRISPR-Cas9 to Temporally Regulate On- and Off-Target Editing.
    Kelkar A; Zhu Y; Groth T; Stolfa G; Stablewski AB; Singhi N; Nemeth M; Neelamegham S
    Mol Ther; 2020 Jan; 28(1):29-41. PubMed ID: 31601489
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CRISPR/Cas9 Engineering of Adult Mouse Liver Demonstrates That the Dnajb1-Prkaca Gene Fusion Is Sufficient to Induce Tumors Resembling Fibrolamellar Hepatocellular Carcinoma.
    Engelholm LH; Riaz A; Serra D; Dagnæs-Hansen F; Johansen JV; Santoni-Rugiu E; Hansen SH; Niola F; Frödin M
    Gastroenterology; 2017 Dec; 153(6):1662-1673.e10. PubMed ID: 28923495
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Strategies for the Generation of Gene Modified Avian Models: Advancement in Avian Germline Transmission, Genome Editing, and Applications.
    Kim YM; Woo SJ; Han JY
    Genes (Basel); 2023 Apr; 14(4):. PubMed ID: 37107658
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A pipeline for rapidly generating genetically engineered mouse models of pancreatic cancer using in vivo CRISPR-Cas9-mediated somatic recombination.
    Ideno N; Yamaguchi H; Okumura T; Huang J; Brun MJ; Ho ML; Suh J; Gupta S; Maitra A; Ghosh B
    Lab Invest; 2019 Jul; 99(8):1233-1244. PubMed ID: 30728464
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.